Viatris Inc (VTRS)

Feb 21, 2025

What's in the Cards for Viatris Stock This Q4 Earnings? - Yahoo Finance

Feb 21, 2025

Feb 21, 2025

Hyperlipidemia Drugs Market Size to Promote USD 31.49 Bn by 2034 - GlobeNewswire Inc.

Feb 21, 2025

Feb 20, 2025

Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline - Yahoo Finance

Feb 20, 2025

Feb 18, 2025

50 Years of Service: From Milkman’s Son to Advancing Access to Medicines - CSRwire.com

Feb 18, 2025

Feb 18, 2025

Viatris Inc.: Is It Time to Sell VTRS Stock Amid Declining Fundamentals?News and Statistics - IndexBox, Inc.

Feb 18, 2025

Feb 17, 2025

HAGENS BERMAN Alerts Viatris (VTRS) Investors to Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys - ACCESS Newswire

Feb 17, 2025

Feb 13, 2025

Viatris Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 13, 2025

Feb 10, 2025

Viatris Inc. stock falls Monday, underperforms market - MarketWatch

Feb 10, 2025

Feb 10, 2025

Hypovolemic Shock Market 2024-2031 | Pfizer Inc, Viatris Inc, - openPR

Feb 10, 2025

Feb 10, 2025

YieldBoost Viatris From 4.5% To 11.1% Using Options - Nasdaq

Feb 10, 2025

Feb 07, 2025

Viatris Inc. stock falls Friday, underperforms market - MarketWatch

Feb 07, 2025

Feb 07, 2025

Pediatric Healthcare Industry May See a Big Move |Boehringer Ingelheim, Glaxosmithkline, Viatris - openPR

Feb 07, 2025

Feb 05, 2025

3 Generic Drug Stocks to Watch - Morningstar

Feb 05, 2025

Feb 05, 2025

Viatris Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq

Feb 05, 2025

Feb 05, 2025

Viatris Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart

Feb 05, 2025

Feb 04, 2025

Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch

Feb 04, 2025

Feb 04, 2025

Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - Nasdaq

Feb 04, 2025

Feb 03, 2025

Here's What to Expect From Viatris' Next Earnings Report - MSN

Feb 03, 2025

Feb 03, 2025

Viatris to Report Fourth Quarter and Full Year 2024 Financial Re - GuruFocus.com

Feb 03, 2025

Feb 03, 2025

Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 – Company Announcement - Financial Times

Feb 03, 2025

Feb 03, 2025

BofA Adjusts Price Target on Viatris to $11 From $12 -February 03, 2025 at 10:50 am EST - Marketscreener.com

Feb 03, 2025

Feb 03, 2025

Viatris Financial Results: Key Q4 and 2024 Performance Data Coming February 27 - StockTitan

Feb 03, 2025

Jan 29, 2025

Viatris And Idorsia Forge Global Partnership For Breakthrough Heart Attack Treatments - MSN

Jan 29, 2025

Jan 29, 2025

VTRS: 3 Hidden Bargains in the Healthcare Sector - StockNews.com

Jan 29, 2025

Jan 27, 2025

Viatris Inc. stock rises Monday, outperforms market - MarketWatch

Jan 27, 2025

Jan 27, 2025

6 New 4-Star Stocks - Morningstar

Jan 27, 2025

Jan 25, 2025

Chris Davis Reduces Stake in Viatris Inc: A Strategic Portfolio Adjustment - GuruFocus.com

Jan 25, 2025

Jan 24, 2025

Viatris: Consolidate In 2025, Win In 2026How 'Phase 2' Of Business Plan May Play Out - Seeking Alpha

Jan 24, 2025

Jan 24, 2025

Here's What To Expect From Viatris' Next Earnings Report - Barchart

Jan 24, 2025

Jan 24, 2025

Lidocaine Patches Market Projected To Witness Substantial Growth, 2025-2032: Sanofi S.A., Viatris Inc., Galen - EIN News

Jan 24, 2025

Jan 23, 2025

Shell says head of downstream and renewables division Vigeveno to step down -January 23, 2025 at 02:27 am EST - Marketscreener.com

Jan 23, 2025

Jan 21, 2025

Taxanes Market: Projected Growth Trends through 2031 | Pfizer - openPR

Jan 21, 2025

Jan 20, 2025

Why Is Viatris Inc. (VTRS) Among the Best High-Yield Dividend Stocks to Invest In? - Insider Monkey

Jan 20, 2025

Jan 16, 2025

EU Antitrust Chief Ribera: Consumer Protections Remain Top Priority - PYMNTS.com

Jan 16, 2025

Jan 16, 2025

Is Viatris Inc. (VTRS) Among Wednesday’s Losers? - MSN

Jan 16, 2025

Jan 16, 2025

Viatris Launch Plans Continue To Drag On, But Confidence High On Quartet - News & Insights

Jan 16, 2025

Jan 15, 2025

Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch

Jan 15, 2025

Jan 15, 2025

Viatris Inc (VTRS) Stock Price Down 4.56% on Jan 15 - GuruFocus.com

Jan 15, 2025

Jan 15, 2025

Is Viatris (VTRS) a Great Value Stock Right Now? - Yahoo Finance

Jan 15, 2025

Jan 14, 2025

Viatris To Present At J.P. Morgan Healthcare Conference; Webcast At 11:15 AM ET - Nasdaq

Jan 14, 2025

Jan 14, 2025

Viatris firm in Cork paid $4bn of dividends as sales fell ahead of announced plant closure - Business Post

Jan 14, 2025

Jan 13, 2025

Systemic Lupus Erythematosus Pipeline Report 2024: Clinical Trials Progress and Therapeutic Advancements | Sanofi SA, Eli Lilly & Company, Viatris Inc., Novartis AG, GlaxoSmithKline, Roche - Barchart

Jan 13, 2025

Jan 13, 2025

Systemic Lupus Erythematosus Pipeline Report 2024: Clinical - openPR

Jan 13, 2025